TG Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Revenue	233.66	2.79	6.69	0.15	0.15	0.15	0.15	0.15	0.15	0.15	Upgrade
Revenue Growth (YoY)	8290.02%	-58.36%	4300.66%	0%	0%	0%	0%	0%	0%	-0.25%	Upgrade
Cost of Revenue	14.13	0.27	0.79	0	0	0	0	0	0	0	Upgrade
Gross Profit	219.53	2.52	5.9	0.15	0.15	0.15	0.15	0.15	0.15	0.15	Upgrade
Selling, General & Admin	122.71	70.01	128.09	107.85	15.03	15.16	16.33	9.89	15.63	15.79	Upgrade
Research & Development	76.19	125.35	222.58	165.9	154.18	159.39	102.53	69.23	47.71	40.09	Upgrade
Operating Expenses	198.9	195.36	350.67	273.75	169.21	174.55	118.86	79.12	63.33	55.87	Upgrade
Operating Income	20.63	-192.84	-344.77	-273.59	-169.06	-174.4	-118.71	-78.97	-63.18	-55.72	Upgrade
Interest Expense / Income	12.62	10.19	5.64	6.33	5.29	0.88	0.85	0	0	0	Upgrade
Other Expense / Income	-5.04	-4.7	-2.31	-0.54	-1.47	-1.8	-1.08	-0.72	-0.23	0.06	Upgrade
Pretax Income	13.06	-198.34	-348.1	-279.38	-172.87	-173.48	-118.48	-78.25	-62.95	-55.78	Upgrade
Income Tax	0.39	0	0	0	0	0	0	0	0	0	Upgrade
Net Income	12.67	-198.34	-348.1	-279.38	-172.87	-173.48	-118.48	-78.25	-62.95	-55.78	Upgrade
Shares Outstanding (Basic)	142	135	132	115	88	75	62	55	46	34	Upgrade
Shares Outstanding (Diluted)	149	135	132	115	88	75	62	-	46	34	Upgrade
Shares Change	9.67%	2.41%	14.64%	30.51%	17.10%	21.58%	13.41%	19.90%	33.98%	34.06%	Upgrade
EPS (Basic)	0.09	-1.46	-2.63	-2.42	-1.96	-2.30	-1.91	-1.60	-1.38	-1.64	Upgrade
EPS (Diluted)	0.09	-1.46	-2.63	-2.42	-1.96	-2.30	-1.91	-1.60	-1.38	-1.64	Upgrade
Free Cash Flow	-31.41	-176.18	-296.04	-214.86	-132.94	-129.02	-93.76	-61.93	-44.73	-35.08	Upgrade
Free Cash Flow Per Share	-0.22	-1.30	-2.24	-1.86	-1.50	-1.71	-1.51	-1.13	-0.98	-1.03	Upgrade
Gross Margin	93.95%	90.48%	88.19%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	8.83%	-6924.20%	-5154.28%	-179996.05%	-111220.39%	-114736.84%	-78100.00%	-51953.29%	-41565.79%	-36658.55%	Upgrade
Profit Margin	5.42%	-7121.54%	-5204.08%	-183803.29%	-113730.92%	-114132.89%	-77944.74%	-51482.24%	-41413.82%	-36698.03%	Upgrade
Free Cash Flow Margin	-13.44%	-6326.18%	-4425.70%	-141357.89%	-87458.55%	-84878.29%	-61685.53%	-40744.08%	-29429.27%	-23077.95%	Upgrade
Effective Tax Rate	2.99%	-	-	-	-	-	-	-	-	-	Upgrade
EBITDA	25.89	-187.84	-342.18	-272.89	-167.48	-172.52	-117.55	-78.19	-62.93	-55.78	Upgrade
EBITDA Margin	11.08%	-6744.74%	-5115.58%	-179535.53%	-110186.84%	-113498.03%	-77334.87%	-51440.79%	-41403.65%	-36695.44%	Upgrade
Depreciation & Amortization	0.21	0.3	0.28	0.16	0.1	0.09	0.08	0.06	0.02	0	Upgrade
EBIT	25.68	-188.14	-342.46	-273.05	-167.58	-172.61	-117.63	-78.25	-62.95	-55.78	Upgrade
EBIT Margin	10.99%	-6755.62%	-5119.79%	-179639.47%	-110252.63%	-113555.92%	-77388.82%	-51482.24%	-41413.82%	-36698.03%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).